Key result
ACE gene PstI allele homozygosity linked to ~130% greater diabetic nephropathy risk in IDDM.
Why the study?
The relationship between DNA polymorphisms in the ACE gene, serum ACE activity, and the risk of diabetic nephropathy in IDDM patients was unclear.
Do DNA polymorphisms in the ACE gene increase the risk of diabetic nephropathy in Jewish IDDM patients?
Case-Control (n=166)
Do DNA polymorphisms in the ACE gene increase the risk of diabetic nephropathy in Jewish IDDM patients?
Genetic variability at the ACE locus, specifically the PstI polymorphism in intron 7, is associated with an increased risk of diabetic nephropathy in IDDM patients.
Answers are grounded in this paper and cite their sources.
May support genetic risk stratification in IDDM; leaves open replication and clinical utility of ACE PstI polymorphism.
BACKGROUND: To determine the relationship between DNA polymorphisms in the angiotensin I converting enzyme (ACE) gene, serum ACE activity and the risk of diabetic nephropathy. METHODS: A case-control study was carried out in a population of Jewish insulin-dependent diabetes mellitus (IDDM) patients. Cases (77 IDDM patients with diabetic nephropathy) and controls (89 IDDM patients with normoalbuminuria) were genotyped with PCR protocols for detecting two DNA polymorphisms in the ACE gene: one in intron 7 detected with the restriction enzyme PstI and the other in intron 16 identified as an insertion/deletion (I/D). RESULTS: The risk of nephropathy was increased only in patients homozygous for the allele with the PstI site. These homozygotes had a nephropathy risk that was 2.3 times (95% C.I.: 1.2-4.5) that of the other genotypes. Furthermore, these individuals did not have elevated serum ACE activity. CONCLUSIONS: The results of this study are evidence that the risk of diabetic nephropathy in IDDM is influenced by genetic variability at the ACE locus, but the responsible variant is not the I/D polymorphism in intron 16. Our findings require further studies in other populations.
No takes yet. Share an insight, caveat, or question.
Manuel Freire (1998) conducted a case-control in insulin-dependent diabetes mellitus (IDDM) (n=166). Homozygosity for the allele with the PstI site in the ACE gene vs. Other genotypes was evaluated on diabetic nephropathy (OR 2.3, 95% CI 1.2-4.5). Homozygosity for the allele with the PstI site in the ACE gene was associated with a 2.3-fold increased risk of diabetic nephropathy in IDDM patients.
Synapse has enriched 10 related papers. Consider them for comparative context: